KSC 2020 | 64th Annual Scientific Meeting of The Korean Society of Cardiology

학술 프로그램

현재 페이지 경로: > Program > 학술 프로그램

전체보기

08:40-10:10

Cardiometabolic Syndrome

Update in SGLT2 Inhibitors from Cardiometabolic Perspective

Channel 01

Chairpersons	Sang-Hyun Kim, Seung Hwan Han
Panel	Se Eun Park, Chan Joo Lee
08:40 - 09:00	HFpEF Malady, Model, Mechanism	[Speaker] Joseph A. Hill/UT Southwestern Medical Center,USA
09:00 - 09:20	SGLT2 Inhibitors Are Heart Failure Drug	[Speaker] Jin Joo Park/Seoul National Univ.,Korea
09:20 - 09:40	No, SGLT2 Inhibitors Are Antidiabetic Medication	[Speaker] Jun Hwa Hong/Eulji Univ.,Korea
09:40 - 10:00	Side Effect in SGLT2 Inhibitor	[Speaker] Sang Man Jin/Sungkyunkwan Univ.,Korea
10:00 - 10:10	Discussion

Heart Failure 1

HF Debate I: Hot Issues in Cardiac Critical Care

Channel 02

Chairpersons	조명찬, 김명아
Panel	김계훈, 박상민, 박재형, 황경국, 황석재
08:40 - 08:52	Pro: Swan-Ganz Catheter in Cardiac Critical Care: It Should Be Done in Some Cases	[Speaker] 양정훈/성균관의대
08:52 - 09:04	Con: Echocardiographic Hemodynamic Monitoring Is Enough	[Speaker] 김미나/고려의대
09:04 - 09:09	Pro Rebuttal	[Speaker] 양정훈/성균관의대
09:09 - 09:14	Con Rebuttal	[Speaker] 김미나/고려의대
09:14 - 09:25	Discussion
09:25 - 09:37	Pro: Awake ECMO, Pros	[Speaker] 이수용/부산의대
09:37 - 09:49	Con: Awake ECMO, Cons	[Speaker] 이선기/한림의대
09:49 - 09:54	Pro Rebuttal	[Speaker] 이수용/부산의대
09:54 - 09:59	Con Rebuttal	[Speaker] 이선기/한림의대
09:59 - 10:10	Discussion

Myocardial Infarction 1

Joint Collaboration for Asian AMI Guideline

Channel 03

Chairpersons	Satoshi Yasuda, Myung Ho Jeong
Panel	Ung Kim, Youngkeun Ahn, Young-Hoon Jeong, Joo-Yong Hahn
08:40 - 09:00	Antithrombotic Therapy in Atrial Fibrillation Patients with Coronary Artery Disease: Shifting Paradigm to a “Less Is More” Concept Regimen	[Speaker] Satoshi Yasuda/National Cerebral and Cardiovascular Center,Japan
09:00 - 09:20	ECMO Application in AMI Patients Complicated with Cardiac Arrest	[Speaker] Bin Liu/Jilin Univ.,China
09:20 - 09:40	Identifying Gaps in AMI Care	[Speaker] Yeo Khung Keong/National Heart Centre,Singapore
09:40 - 10:00	Consensus Document for Korean AMI	[Speaker] Kiyuk Chang/Catholic Univ.,Korea
10:00 - 10:10	Discussion

Basic Research

Hotline Issues in Cardiovascular Diseases

Channel 04

Chairpersons	Jin Han, Yin Hua Zhang
Panel	Ki-Hwan Kwon, Jang-Whan Bae, Woo Cheol Chang
08:40 - 08:55	New Insights on Diabetic Cardiomyopathy	[Speaker] Barbara Casadei/Univ. of Oxford,UK
08:55 - 09:10	Molecular Mechanism of Obesity-induced Hypertension	[Speaker] Young-Myeong Kim/Kangwon National Univ.,Korea
09:10 - 09:25	Altered Shear Stress Response in Atrial Myocytes from Failed Heart	[Speaker] Sun Hee Woo/Chungnam National Univ.,Korea
09:25 - 09:40	Inter-mitochondrial Communication and the Pathophysiological Relevance in the Heart	[Speaker] Ming Zheng/Peking Univ.,China
09:40 - 10:10	Discussion

10:20-11:50

Cross Specialty: Gastroenterology & Intervention

Channel 01

Chairpersons	권현철, 김두일
Panel	구본권, 권기환
	1. Skip or Continue Antiplatelet Therapy before Endoscopic Procedure
10:20 - 10:35	Why Cardiologists Are Uncomfortable to Skip Antiplatelet Therapy?, and My Solution	[Speaker] 정영훈/경상의대
10:35 - 10:50	Why Endoscopists Are Uncomfortable to Continue Antiplatelet Therapy?, and My Solution	[Speaker] 이준행/성균관의대
10:50 - 11:05	Discussion
	2. Cardiovascular Drug Induced Hepatitis
11:05 - 11:20	Cardiovascular Drugs Which Requires Attention for Hepatic Dysfunction	[Speaker] 박경일/동아의대
11:20 - 11:35	Why You Have to Stop Cardiovascular Drugs Due to Hepatic Dysfunction and How to Restart?	[Speaker] 김동준/한림의대
11:35 - 11:50	Discussion

Heart Failure 2

HF 2020 at a Glance

Channel 02

Chairpersons	유규형, 최동주
Panel	김성해, 김응주, 박대균, 최성훈, 최의영, 최진오
10:20 - 10:35	Updates in HFrEF Treatment: From SOLVD to VICTORIA	[Speaker] 윤종찬/가톨릭의대
10:35 - 10:45	HFrEF Designated Discussion	[Speaker] 유병수/연세원주의대
10:45 - 11:00	Never Ending Story of Failure: HFpEF Treatment	[Speaker] 박진주/서울의대
11:00 - 11:10	HFpEF Designated Discussion	[Speaker] 박성지/성균관의대
11:10 - 11:25	ICD/CRT in HF: Something You May Not Know, but Should Know	[Speaker] 이상언/울산의대
11:25 - 11:35	ICD/CRT Designated Discussion	[Speaker] 박승정/성균관의대
11:35 - 11:50	Discussion

Imaging

Coronary Plaque Imaging

Channel 03

Chairpersons	최연현, 송재관
Panel	강원준, 양동현, 이주희, 최상일
10:20 - 10:40	Coronary Plaque Imaging: Why Should We Do?	[Speaker] 이철환/울산의대
10:40 - 11:00	Coronary Plaque: Invasive Imaging	[Speaker] 강수진/울산의대
11:00 - 11:20	Coronary Plaque: CT Imaging	[Speaker] 이상은/이화의대
11:20 - 11:40	Coronary Plaque: Nuclear Imaging	[Speaker] 조상건/전남의대
11:40 - 11:50	Discussion

Arrhythmia 1

AF Screening and Stroke Prevention

Channel 04

Chairpersons	김준수, 최기준, 김대경
Panel	김민수, 반지은, 배명환
10:20 - 10:30	The Trend and Burden of Korean AF	[Speaker] 양필성/차의대
10:30 - 10:40	Risk Stratification of Thromboembolism	[Speaker] 이광노/아주의대
10:40 - 10:50	Imaging Modalities for AF Treatment	[Speaker] 이정명/경희의대
10:50 - 11:00	Korean Practical Guideline of NOAC Use	[Speaker] 박진규/한양의대
11:00 - 11:10	Selection of NOAC	[Speaker] 이소령/서울의대
11:10 - 11:20	Wearable Monitoring and Opportunistic Screening of AF: State of the Art	[Speaker] 백용수/인하의대
11:20 - 11:30	How to Apply Korean Anticoagulation Guideline in PCI Patients	[Speaker] 황유미/가톨릭의대
11:30 - 11:40	Non-genetic Risk Factor for AF	[Speaker] 김윤기/고려의대
11:40 - 11:50	Discussion

12:00-13:30

Scientific Session [Pfizer Upjohn]

Evidence Based Strategies: Optimizing an ASCVD Management

Channel 01

Chairpersons	한규록, 김용진
12:00 - 12:20	Highlighting Atorvastatin`s CV Protection Evidence in the Last Few Decades	[Speaker] 이준희/한림의대
12:20 - 12:40	Amlodipine, 30 Years of Evidence in Hypertension Treatment: Now from Children to Adults	[Speaker] 손일석/경희의대

Scientific Session [Amgen]

The Earlier, The Better: An Ideal Approach with PCSK9 Inhibition in ACS Patients

Channel 02

Chairpersons	정명호, 김효수
12:00 - 12:15	The Importance of LDL-C Lowering with Evolocumab in Recent ACS	[Speaker] 서정원/서울의대
12:15 - 12:30	PCSK9 Inhibition: Beyond LDL-C Lowering Effect in ACS Patients	[Speaker] 정영훈/경상의대
12:30 - 12:40	Discussion

Scientific Session [Boryung]

What`s New in Cardiovascular Disease Risk Management

Channel 03

Chairpersons	이만영, 강석민
12:00 - 12:20	Facing the Challenge of Hypertension and Dyslipidemia Management	[Speaker] 신진호/한양의대
12:20 - 12:40	Outcomes after Use of 110mg Dabigatran in Patients with AF	[Speaker] 임우현/서울의대

Diamond Session [BMS/Pfizer]

Anticoagulation Management in NVAF: Optimizing Patient Outcomes

Channel 04

Chairpersons	김대혁, 정보영
12:00 - 12:20	The Evolution of the ESC Atrial Fibrillation Management Guideline	[Speaker] 신승용/중앙의대
12:20 - 12:40	Long-term Persistence and Adherence in Patients with Atrial Fibrillation: Impact of Dosing Frequency	[Speaker] 박승정/성균관의대

Lipid

Management of Dyslipidemia in Diverse Diseases

Channel 05

Chairpersons	김치정, 정인경
Panel	김학령, 박훈준, 서원우, 안효석, 조준환
12:00 - 12:20	Dyslipidemia Management in Diabetes	[Speaker] 정인경/경희의대
12:20 - 12:40	Dyslipidemia Management in Stroke	[Speaker] 류위선/동국의대
12:40 - 13:00	Dyslipidemia Management in Kidney Disease	[Speaker] 이규백/성균관의대
13:00 - 13:20	Dyslipidemia Management in Coronary Artery Disease	[Speaker] 조상호/한림의대
13:20 - 13:30	Discussion

14:00-15:30

Myocardial Infarction 2

Recent Updates in AMI

Channel 01

Chairpersons	김효수, 차광수
Panel	문재연, 서존, 이장훈, 이중희, 황진용
14:00 - 14:20	Impact of Recent AMI Trials on My Daily Practice: COMPLETE, ISAR-REACT 5, CULPRIT SHOCK, COAPT	[Speaker] 이상엽/충북의대
14:20 - 14:40	PCI for Nonculprit Lesion in STEMI: Assessment, Timing and Outcome	[Speaker] 고진신/경상의대
14:40 - 15:00	How to Improve Suboptimal Reperfusion in STEMI?	[Speaker] 추은호/가톨릭의대
15:00 - 15:20	Challenges in Reperfusion for STEMI in the COVID-19 Pandemics	[Speaker] 김정수/부산의대
15:20 - 15:30	Discussion

Cross Specialty: Arrhythmia & Heart Failure

Clinical Challenges: AF and HF

Channel 02

Chairpersons	최동주, 오용석
14:00 - 14:10	Introduction- Incidence Epidemiology Risk	[Speaker] 양필성/차의대
14:10 - 14:20	AF Causing HF Versus HF Causing AF: Can We Tell One from the Other	[Speaker] 김응주/고려의대
14:20 - 14:30	Optimal Management of the Patients with AF and HF: Anticoagulation and Antiarrhythmic Drugs	[Speaker] 최종일/고려의대
14:30 - 14:40	Optimal Management of the Patients with AF and HF: Beta-blocker Still Useful?	[Speaker] 박진주/서울의대
14:40 - 14:50	Role of AF Ablation in HF - AF Ablation vs. AV Node Ablation and CRT as Primary Therapy	[Speaker] 박형섭/계명의대
14:50 - 15:00	AF in HF: Ablate or Not?	[Speaker] 이상언/울산의대
15:00 - 15:30	Discussion

Echocardiography 1

Mitral Regurgitation: From Diagnosis to Treatment

Channel 03

Chairpersons	권준, 하종원
Panel	김형윤, 손일석, 정욱진, 최의영
14:00 - 14:20	Comprehensive Analysis of Mitral Regurgitation Using TTE, TEE and 3D Echocardiography	[Speaker] 조익성/연세의대
14:20 - 14:40	Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework from Mitraclip Trials	[Speaker] 박성지/성균관의대
14:40 - 15:00	Echocardiographic Evaluation and Procedure Monitoring in Percutaneous Mitral Intervention	[Speaker] 김대희/울산의대
15:00 - 15:20	Surgical Mitral Valve Repair: Where We Stand?	[Speaker] 유재석/세종병원
15:20 - 15:30	Discussion

Cardiac Surgery

In the Era of MCS, Are We Transplanting the Heart More to Moribund Patients?

Channel 04

Chairpersons	양지혁, 정성호
Panel	강준규, 김준성, 이재진
14:00 - 14:15	Selection Criteria for Candidates and Current Status of Heart Transplant in Korea	[Speaker] 김순영/국립장기조직혈액관리원
14:15 - 14:30	Heart Transplant with or without MCS: Trends in Korea	[Speaker] 조양현/성균관의대
14:30 - 14:45	Factors Affecting the Long-term Outcome of Heart Transplant in the Era of MCS	[Speaker] 황호영/서울의대
14:45 - 15:00	How Can We Overcome the Shortage of Donors?	[Speaker] 정재승/고려의대
15:00 - 15:30	Discussion

15:40-17:10

Women Heart Disease

Immunity and Heart

Channel 01

Chairpersons	김명아, 홍경순
Panel	김인철, 김장영, 박성미, 정진옥
15:40 - 16:00	Immune and Heart	[Speaker] 김학령/서울의대
16:00 - 16:20	Autoimmune Related Cardiac Disease	[Speaker] 김미나/고려의대
16:20 - 16:40	Viral Infection and Heart	[Speaker] 변영섭/인제의대
16:40 - 17:00	Vaccination and Heart	[Speaker] 김형윤/전남의대
17:00 - 17:10	Discussion

New Frontiers in Cardiology 1: Heart Failure

Heart Failure 2020

Channel 02

Chairpersons	김기식, 최동주
Panel	김민석, 윤종찬, 최성훈, 최진오
15:40 - 16:00	HF Epidemiology, Awareness and Performance Measures	[Speaker] 유병수/연세원주의대
16:00 - 16:20	Update on Recent HF Guidelines	[Speaker] 조현재/서울의대
16:20 - 16:40	Surgical Treatment of Advanced HF: HTx and LVAD	[Speaker] 정성호/울산의대
16:40 - 17:10	Discussion

JCS-KSC Joint Session: Cardiometabolic Syndrome

SGLT2 Inhibitor vs. GLP1 Analogue for Cardiometabolic Syndrome

Channel 03

Chairpersons	Motoaki Sano, Soo Lim
Panel	Sang Hyun Ihm
15:40 - 16:00	Selective Roles of SGLT2 Inhibitors and GLP-1 Analogues to Reduce Cardiovascular Risk	[Speaker] In Chang Hwang/Seoul National Univ.,Korea
16:00 - 16:20	Efficacy and Mechanism of Action of SGLT2 Inhibitors in Heart Failure	[Speaker] Motoaki Sano/Keio Univ.,Japan
16:20 - 16:40	Novel Duo for Cardiometabolic Syndrome: SGLT2 Inhibitors and GLP-1	[Speaker] Jun Sung Moon/Youngnam Univ.,Korea
16:40 - 17:00	Natriuretic Effect of SGLT2 and Its Mechanisms in Patients with HF and T2DM	[Speaker] Kaoru Dohi/Mie Univ.,Japan
17:00 - 17:10	Discussion

Cardiac Pathology

Cardiac Conduction System in Human Heart

Channel 04

Chairpersons	June Huh, Seil Oh
Panel	Jin-Seok Kim, Jeong Wook Seo, Mi Kyoung Song, Jae-Sun Uhm, Hee Tae Yu, Won-Seok Choi
15:40 - 16:00	Embryology of Conduction System	[Speaker] Jung Sun Kim/Sungkyunkwan Univ.,Korea
16:00 - 16:20	His-purkinje System	[Speaker] Il-Young Oh/Seoul National Univ.,Korea
16:20 - 16:40	Cardiac Conduction System for Electrophysiologist	[Speaker] S Yen Ho/Royal Brompton Hospital,UK
16:40 - 17:00	Cardiac Conduction System in Congenital Heart Disease	[Speaker] S Yen Ho/Royal Brompton Hospital,UK
17:00 - 17:10	Discussion

17:20-18:50

Epidemiology

국민건강보험빅데이터(NHI-BD)를 이용한 심혈관질환 역학연구

Channel 01

Chairpersons	김동욱, 이해영
Panel	김헌성, 성기철, 이호규
17:20 - 17:40	고혈압 및 심혈관질환 역학연구	[Speaker] 김현창/연세의대
17:40 - 18:00	당뇨병 및 심혈관질환 역학연구	[Speaker] 이상열/경희의대
18:00 - 18:20	심혈관계 약물의 비교효과 연구	[Speaker] 유승찬/아주의대
18:20 - 18:40	만성질환 질병 부담 평가 연구	[Speaker] 조민우/울산의대
18:40 - 18:50	Discussion

Nurse-Technician Session

Changes in the Environment of Cath Rooms

Channel 02

Chairpersons	이민석, 박은심
Panel	강준원, 김태우, 박경진, 백성일, 이규성, 이승훈, 이현진
17:20 - 17:40	Recent Trends in Cathroom Configuration (Hardware Setup)	[Speaker] 이하준/고대안암병원
17:40 - 18:00	Introducing the Latest Device Updates	[Speaker] 이승현/강남세브란스병원
18:00 - 18:20	PCI Procedure under the Support Ecmo	[Speaker] 박상만/삼성서울병원
18:20 - 18:40	Changes in Cathroom Procedure Environment Due to COVID-19	[Speaker] 김선배/서울아산병원
18:40 - 18:50	Discussion

Smart Health

Remote Monitoring of Cardiovascular Diseases

Channel 03

Chairpersons	박승우, 김영학
Panel	양정훈, 윤창환, 이민호
17:20 - 17:35	Remote Monitoring by Implantable Devices	[Speaker] 정보영/연세의대
17:35 - 17:50	Remote Monitoring by Wearable Devices	[Speaker] 오일영/서울의대
17:50 - 18:05	Ubiquitous Blood Pressure Monitoring by New Technologies	[Speaker] 박준빈/서울의대
18:05 - 18:20	Pro and Cons of Telemonitoring of ICU	[Speaker] 전기현/메디플렉스세종병원
18:20 - 18:50	Discussion

Intervention 1

Which Evidence-Based NOAC Should Be the Preferred Dual Anti-thrombotic Regimen in AF Patients Undergoing PCI?

Channel 04

Chairpersons	한규록, 안영근
Panel	강웅철, 김성은, 김중선, 도준형, 홍영준
17:20 - 17:35	P2Y12 Inhibitor with Rivaroxaban	[Speaker] 박경우/서울의대
17:35 - 17:50	P2Y12 Inhibitor with Dabigatran	[Speaker] 서석민/가톨릭의대
17:50 - 18:05	P2Y12 Inhibitor with Apixaban	[Speaker] 임홍석/아주의대
18:05 - 18:20	P2Y12 Inhibitor with Edoxaban	[Speaker] 박재형/고려의대
18:20 - 18:50	Discussion